| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |